Cantor Fitzgerald Issues Positive Estimate for BMRN Earnings
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) – Equities research analysts at Cantor Fitzgerald lifted their FY2025 earnings estimates for shares of BioMarin Pharmaceutical in a report released on Friday, May 2nd. Cantor Fitzgerald analyst O. Brayer now anticipates that the biotechnology company will post earnings per share of $3.61 for the year, up from […]
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) – Equities research analysts at Cantor Fitzgerald lifted their FY2025 earnings estimates for shares of BioMarin Pharmaceutical in a report released on Friday, May 2nd. Cantor Fitzgerald analyst O. Brayer now anticipates that the biotechnology company will post earnings per share of $3.61 for the year, up from […]
